In an era where the reliability and reproducibility of biomedical research have received much scrutiny, the precision medicine approaches presented in this symposium illustrate the translation of sound science into effective therapeutic interventions for patients, particularly in diseases like CF where patients with rare CFTR mutations render traditional randomized controlled trials unfeasible. Here, CFTR is linked to cystic fibrosis.